Figure 4
Figure 4. TF-induced venous thromboembolism model. (A) Anesthetized mice were injected intravenously with recombinant TF (1/8 dilution of Innovin in 0.9% NaCl; 2 μL/g body weight) via the inferior vena cava. The time to the onset of respiratory arrest that lasted at least 2 minutes was recorded for WT (■; n = 8) and Pros+/− (△; n = 8) mice. Experiments were terminated at 20 minutes. Pros+/− mice showed higher mortality than WT mice (P = .02), and 87.5% WT mice and 25% Pros+/− mice survived the TF challenge. (B) In the low-TF challenge and 2 minutes after onset of respiratory arrest or at the completion of the 20-minute observation period, lungs were excised and stained with H&E. Pros+/− mice that died within the 20-minute observation period had an increased number of thrombi (arrows, right panel), compared with WT mice that survived the TF challenge (left panel).

TF-induced venous thromboembolism model. (A) Anesthetized mice were injected intravenously with recombinant TF (1/8 dilution of Innovin in 0.9% NaCl; 2 μL/g body weight) via the inferior vena cava. The time to the onset of respiratory arrest that lasted at least 2 minutes was recorded for WT (■; n = 8) and Pros+/− (△; n = 8) mice. Experiments were terminated at 20 minutes. Pros+/− mice showed higher mortality than WT mice (P = .02), and 87.5% WT mice and 25% Pros+/− mice survived the TF challenge. (B) In the low-TF challenge and 2 minutes after onset of respiratory arrest or at the completion of the 20-minute observation period, lungs were excised and stained with H&E. Pros+/− mice that died within the 20-minute observation period had an increased number of thrombi (arrows, right panel), compared with WT mice that survived the TF challenge (left panel).

Close Modal

or Create an Account

Close Modal
Close Modal